• Home
  • Facilities
  • Services
  • NEWS AND EVENTS
  • People
  • Contact us
MCIF Lab - Cyclotron and Radiopharmaceutical Research and Development Facility

Molecular Cancer Imaging Facility (MCIF)
CYCLOTRON AND RADIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT FACILITY

News and Events


August 2020

Publication:
​Synthesis of a 11C-Isotopologue of the B-Raf-Selective Inhibitor Encorafenib Using In-Loop [11C]CO2 Fixation.
Dornan MH, Petrenyov D, Simard JM, Boudjemeline M, Mititelu R, DaSilva JN, Belanger AP.
ACS Omega. 2020 Aug 16;5(33):20960-20966.

June 2020

Research Grant Awarded:
SNMMI 2020 Mitzi & William Blahd, MD, Pilot Research Grant "Development of a PET radiotracer for imaging KRAS G12C in NSCLS" Mark Dornan, Ph.D.

January 2020

Promotion:
Anthony Belanger, Ph.D. promoted to Scientific Director, Lead Scientist in MCIF

October 2019

Research Grant Awarded:
DFCI Friends of DFCI 2020 Award "The first in vivo-evaluation of BRAF PET imaging"  Mark Donan, Ph.D.

December 2018

Appointment:
​Moritz Kircher, M.D., Ph.D. named Chair Department of Imaging and Radiology, DFCI  www.dana-farber.org/newsroom/news-releases/2018/moritz-kircher--md--phd--named-chair-of-dana-farber-department-of-imaging-and-radiology/

August 2018

Oral Presentation:
"
Galileo- An automated synthesis module for development and manufacturing of novel radio-metallic tracers."
17th Workshop on Targetry and Target Chemistry
Coimbra, Portugal

 HOME | FACILITIES | SERVICES | NEWS AND EVENTS | PEOPLE | CONTACT US

©2018 MCIF at Dana-Farber Cancer Institute